JP2004503217A5 - - Google Patents

Download PDF

Info

Publication number
JP2004503217A5
JP2004503217A5 JP2002500917A JP2002500917A JP2004503217A5 JP 2004503217 A5 JP2004503217 A5 JP 2004503217A5 JP 2002500917 A JP2002500917 A JP 2002500917A JP 2002500917 A JP2002500917 A JP 2002500917A JP 2004503217 A5 JP2004503217 A5 JP 2004503217A5
Authority
JP
Japan
Prior art keywords
ligand
cell
host cell
presenting
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002500917A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004503217A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/017454 external-priority patent/WO2001092306A2/en
Publication of JP2004503217A publication Critical patent/JP2004503217A/ja
Publication of JP2004503217A5 publication Critical patent/JP2004503217A5/ja
Pending legal-status Critical Current

Links

JP2002500917A 2000-05-31 2001-05-30 卵巣癌のための治療化合物 Pending JP2004503217A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20938800P 2000-05-31 2000-05-31
US25700700P 2000-12-20 2000-12-20
PCT/US2001/017454 WO2001092306A2 (en) 2000-05-31 2001-05-30 Therapeutic compounds for ovarian cancer

Publications (2)

Publication Number Publication Date
JP2004503217A JP2004503217A (ja) 2004-02-05
JP2004503217A5 true JP2004503217A5 (https=) 2005-02-17

Family

ID=26904120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002500917A Pending JP2004503217A (ja) 2000-05-31 2001-05-30 卵巣癌のための治療化合物

Country Status (8)

Country Link
US (2) US6737062B2 (https=)
EP (1) EP1284997B1 (https=)
JP (1) JP2004503217A (https=)
AT (1) ATE292640T1 (https=)
AU (1) AU2001265188A1 (https=)
CA (1) CA2410895A1 (https=)
DE (1) DE60109922D1 (https=)
WO (1) WO2001092306A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004503217A (ja) 2000-05-31 2004-02-05 ジェンザイム・コーポレーション 卵巣癌のための治療化合物
JP2004514412A (ja) * 2000-05-31 2004-05-20 ジェンザイム・コーポレーション 卵巣癌のための治療化合物
CA2438505A1 (en) * 2001-02-14 2002-09-12 Genzyme Corporation Altered peptide ligands
WO2002080845A2 (en) * 2001-04-04 2002-10-17 Genzyme Corporation Novel eps8 compounds for therapy and diagnosis and methods for using same
AU2002232563A1 (en) * 2001-12-05 2003-06-23 Genzyme Corporation Compounds for therapy and diagnosis and methods for using same
WO2003068925A2 (en) * 2002-02-11 2003-08-21 Mosca Joseph D Production of a protein delivery system for in vivo therapeutic treatment
JP2005191530A (ja) * 2003-12-03 2005-07-14 Sumitomo Electric Ind Ltd 発光装置
US20110129550A1 (en) * 2007-02-16 2011-06-02 Connie Erickson-Miller Cancer treatment method
US20110160130A1 (en) * 2007-02-16 2011-06-30 Connie Erickson-Miller Cancer treatment method
UY30915A1 (es) * 2007-02-16 2008-09-02 Smithkline Beecham Corp Método de tratamiento de canceres
EA022915B1 (ru) * 2007-10-09 2016-03-31 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Способы лечения острого миелоидного лейкоза и миелодиспластического синдрома

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4754065A (en) 1984-12-18 1988-06-28 Cetus Corporation Precursor to nucleic acid probe
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5837249A (en) 1985-04-19 1998-11-17 The Wistar Institute Method for generating an immunogenic T cell response protective against a virus
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5688657A (en) 1988-03-31 1997-11-18 International Bio-Immune Systems, Inc. Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
WO1992013878A2 (en) 1991-02-07 1992-08-20 Board Of Trustees Of The University Of Illinois Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
JPH07101999A (ja) 1993-10-06 1995-04-18 Hagiwara Yoshihide 抗癌ヒトモノクローナル抗体に対する抗イデイオタイプ抗体のアミノ酸配列およびそれをコードするｄｎａ塩基配列
US5643786A (en) 1995-01-27 1997-07-01 The United States Of America As Represented By The Department Of Health And Human Services Method for isolating dendritic cells
DE19817946A1 (de) 1998-04-17 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Uterus-Normalgewebe
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
AU3087801A (en) 2000-02-04 2001-08-14 Molecular Dynamics Inc Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells
JP2004503217A (ja) 2000-05-31 2004-02-05 ジェンザイム・コーポレーション 卵巣癌のための治療化合物

Similar Documents

Publication Publication Date Title
JP2006511196A5 (https=)
WO2005037190A3 (en) Multiplex vaccines
JP2006514920A5 (https=)
JP2006020648A5 (https=)
JP2004503217A5 (https=)
EP2361930A3 (en) Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
JP2007538044A5 (https=)
JP2013502918A5 (https=)
DE602004031017D1 (de) Zusammensetzung verpackte virusartige teilchen umfassend zur verstärkung einer immunantwort
HUP0004327A3 (en) Fusion proteins containing human papilloma virus (hpv) proteins and immunological fusion partner with t-helper epitopes to the hpv antigen, as well as vaccine formulations for treatment and/or profilaxis of hpv induced lesions
CN101745104B (zh) 含有复合佐剂的结核亚单位疫苗
JP2007504237A5 (https=)
JP2003519099A5 (https=)
JP2005504513A5 (https=)
JP2009515831A5 (https=)
WO2003070187A3 (en) Fusion proteins of mycobacterium tuberculosis
BR0314373A (pt) Produto imunogênico estável para a indução de anticorpos contra uma ou várias proteìnas antigênicas em um indivìduo, composições farmacêutica, imunogênica e de vacina e processo de preparação de um produto imunogênico
CA2285018A1 (en) Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
BR0010711A (pt) Uso de moléculas co-estimulatórias solúveis para intensificar respostas imunes
DK1267924T3 (da) Immunterapeutiske metoder og sammensætninger
JP2004510160A5 (https=)
AU2002354806A1 (en) Parathyroid hormone antibodies and related methods
WO2002054073A3 (en) Latent human tuberculosis model, diagnostic antigens, and methods of use
AU2003242535A1 (en) Improved polysaccharide and glycoconjugate vaccines
WO2003089584A3 (en) Use of parapox b2l protein to modify immune responses to administered antigens